Kyndryl Holdings, Inc. Form 8-K Summary
Business context and reporting period
Kyndryl Holdings, Inc. filed this Form 8-K on February 24, 2022, with a signature date of February 25, 2022. The filing concerns executive compensation arrangements and the scheduling and stockholder submission deadlines for Kyndryl’s first annual meeting of stockholders. It does not report quarterly or annual operating results.
Key financial and corporate matters
- The Compensation Committee adopted the Kyndryl Annual Incentive Plan for Executives, a cash-based plan covering selected executives, including the named executive officers.
- For the transition performance period from January 1 through March 31, 2022, target cash bonus opportunities were set at 200% of base salary for Martin Schroeter and Elly Keinan, and 125% of base salary for David Wyshner, Edward Sebold, and Maryjo Charbonnier, with each opportunity prorated for the three-month period.
- Actual payouts may range from 0% to 200% of the target opportunity. The primary performance measures are equally weighted revenue and Adjusted EBITDA goals, with a potential adjustment of up to 10% based on backlog improvement and advisory and implementation services signings.
- The filing provides no reported revenue, profit, cash flow, margin, debt, liquidity, or other operating metrics for the period.
Material changes, outlook, risks, and unusual items
- The Executive Severance Plan and Executive Retirement Policy were amended. For a covered termination, severance will be paid in a lump sum rather than through salary continuation: 24 months of base salary for Mr. Schroeter and 18 months for the other named executive officers.
- Mr. Schroeter’s continued health insurance coverage or premium reimbursement following a covered termination, including one occurring within 24 months after a change in control, was reduced from 24 months to 18 months.
- The Compensation Committee may adjust incentive metrics, targets, and payouts, subject to applicable law, including for unforeseen circumstances. The filing therefore leaves substantial discretion over final awards.
- The Company’s first annual meeting of stockholders will be held on July 28, 2022.
- The deadline for Rule 14a-8 proposals intended for inclusion in proxy materials is March 7, 2022. Other proposals, director nominations, and proxy-access requests must generally be received by April 29, 2022.
Important facts for investors to verify
- Review Exhibits 10.1 and 10.2 for the complete incentive-plan definitions, performance conditions, discretion, severance terms, and change-in-control provisions.
- Verify the final revenue and Adjusted EBITDA performance results and any strategic-goal adjustments when the transition-period awards are determined.
- Monitor subsequent filings for actual executive compensation expense, bonus payouts, and any further amendments to severance or retirement arrangements.
- Review the proxy materials and annual meeting disclosures for governance matters, director nominations, and stockholder proposals.